Generate PMS data to assess patient safety : CDSCO Panel Tells Novartis Healthcare on additional indications of Secukinumab Dr. Divya Colin17 March 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major...
Submit efficacy data of Indian population: CDSCO Panel Tells Eli Lilly for approval of additional indications of Ixekizumab Dr. Divya Colin9 Oct 2024 6:00 PM ISTNew Delhi: Citing that there is no efficacy data in the Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Use of immunosuppressive agents may increased fracture risk among patients with autoimmune diseases Niveditha Subramani26 Jan 2024 1:30 AM ISTSeveral studies have investigated the association between immunosuppressive agents and fracture risk in patients with autoimmune diseases. The...
FDA approves intravenous Secukinumab for Rheumatic diseases Dr. Kamal Kant Kohli11 Oct 2023 11:45 AM ISTThe US Food and Drug Administration (FDA) has approved an intravenous formulation of Secukinumab for patients with psoriatic arthritis, ankylosing...
Novartis Cosentyx IV formulation for rheumatic diseases bags USFDA okay Ruchika Sharma10 Oct 2023 1:30 PM ISTThe IV formulation of Cosentyx offers patients a monthly 30-minute, weight-based dosing option, requiring no pre-medication and no lab monitoring.
Opioid use in Ankylosing spondylitis major risk of fracture Niveditha Subramani24 Aug 2023 8:00 PM ISTAnkylosing spondylitis (AS) is a rare type of arthritis that mainly affects the back, by causing inflammation in the spine. AS occurs more...
USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz Ruchika Sharma22 March 2023 1:45 PM ISTSandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.
Man bedridden for 4 years walks day after surgery in Delhi Roshni Dhar17 March 2023 5:42 PM ISTDoctors at Sir Ganga Ram Hospital performed a seven-hour surgical procedure for simultaneous bilateral hip replacement for ankylosing spondylitis on a...
Posterior percutaneous long-segment internal fixation effective for thoracolumbar fractures in ankylosing spondylitis Dr. Shravani Dali1 Dec 2022 7:30 PM ISTPosterior percutaneous long-segment internal fixation effective in treating thoracolumbar fractures in ankylosing spondylitis patients suggests a...
Secukinumab has low malignancy risk in patients of Psoriasis and psoriatic arthritis: Study MD Bureau2 July 2021 9:00 AM ISTPsoriasis is an auto-immune disease that causes red, scaly patches to occur on the skin. It is a chronic disease and is caused, at least in part, by...
Tofacitinib is Effective in the Treatment of Ankylosing spondylitis MD Bureau5 Jun 2021 9:00 AM ISTThe Assessment of SpondyloArthritis international Society (ASAS)/European League Against Rheumatism and American College of Rheumatology/Spondylitis...
Manifestation of Ankylosing spondylitis after kidney transplant: A Case report MD Bureau10 Feb 2021 8:57 PM ISTThe appearance of inflammatory and autoimmune diseases is quite low in patients after solid organ transplantation. Adequate immunosuppressive therapy...
